2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Disease Free Survival: new trials by email Literature Review of Disease Free Survival trials Research Report on Disease Free Survival
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer bevacizumab, DDP, Docetaxel - Disease Free Survival | Phase 2 / Phase 3 | Unknown | Air Force Military Medical University, China | 150 | 2020-08-01 | 2020-06-30 |
| Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME, concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX - Rectal Cancer, Pathological Complete Response | Phase 2 | Unknown | Peking University People's Hospital | 244 | 2018-01-31 | 2023-03-22 |
Rectal Neoplasms (1)
Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Bevacizumab (1) · Cisplatin (1) · Docetaxel (1) · Radiotherapy (1)
Air Force Military Medical University, China (1) · Peking University People's Hospital (1)
China (2)
PMID 20106720, PMID 21066983, PMID 21596621, PMID 21747092, PMID 22367706, PMID 22529255, PMID 26187751, PMID 26189067, PMID 27254838, PMID 27480145